PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Khan E and Abu-Amer Y Activation of peroxisome proliferator-activated receptor-gamma inhibits differentiation of preosteoblasts. 2003 J. Lab. Clin. Med. pmid:12878983
Yuan ZY et al. [Peroxisome proliferation-activated receptor-gamma ligands ameliorate autoimmune myocarditis associated with inhibition of T cell immunity]. 2003 Zhonghua Yi Xue Za Zhi pmid:14703419
Ceaser EK et al. Oxidized low-density lipoprotein and 15-deoxy-delta 12,14-PGJ2 increase mitochondrial complex I activity in endothelial cells. 2003 Am. J. Physiol. Heart Circ. Physiol. pmid:12881207
Genovese A et al. Protein Fv produced during viral hepatitis is an endogenous immunoglobulin superantigen activating human heart mast cells. 2003 Int. Arch. Allergy Immunol. pmid:14707465
Aoun P et al. Neuroprotective effects of PPARgamma agonists against oxidative insults in HT-22 cells. 2003 Eur. J. Pharmacol. pmid:12860474
Zanoni G et al. First total synthesis of JS isoprostane. 2003 J. Org. Chem. pmid:12868940
Zahradka P et al. Activation of peroxisome proliferator-activated receptors alpha and gamma1 inhibits human smooth muscle cell proliferation. 2003 Mol. Cell. Biochem. pmid:12841350
Keelan JA et al. Cytokines, prostaglandins and parturition--a review. 2003 Placenta pmid:12842412
Chen CW et al. Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway. 2003 J. Immunol. pmid:12847270
Date M et al. 15-Deoxy-delta12,14-prostaglandin J2, a ligand for peroxisome proliferators-activated receptor-gamma, induces apoptosis in human hepatoma cells. 2003 Liver Int. pmid:14986820
Piliponsky AM et al. Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor. 2003 Blood pmid:12393403
Lee TS et al. Induction of heme oxygenase-1 expression in murine macrophages is essential for the anti-inflammatory effect of low dose 15-deoxy-Delta 12,14-prostaglandin J2. 2003 J. Biol. Chem. pmid:12642589
Pavan L et al. Human invasive trophoblasts transformed with simian virus 40 provide a new tool to study the role of PPARgamma in cell invasion process. 2003 Carcinogenesis pmid:12807721
Guyton K et al. Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli. 2003 Shock pmid:12813370
Burgermeister E et al. Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells. 2003 Oncogene pmid:12813462
Satoh T et al. Role of heme oxygenase-1 protein in the neuroprotective effects of cyclopentenone prostaglandin derivatives under oxidative stress. 2003 Eur. J. Neurosci. pmid:12814358
Ianaro A et al. Anti-inflammatory activity of 15-deoxy-delta12,14-PGJ2 and 2-cyclopenten-1-one: role of the heat shock response. 2003 Mol. Pharmacol. pmid:12815164
Hashimoto K et al. The PPARgamma ligand, 15d-PGJ2, attenuates the severity of cerulein-induced acute pancreatitis. 2003 Pancreas pmid:12826907
Zingarelli B et al. Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways. 2003 J. Immunol. pmid:14662889
Urade Y et al. Sleep regulation in adenosine A2A receptor-deficient mice. 2003 Neurology pmid:14663019
Montuschi P et al. Exhaled leukotrienes and prostaglandins in COPD. 2003 Thorax pmid:12832671
Placha W et al. The effect of PPARgamma ligands on the proliferation and apoptosis of human melanoma cells. 2003 Melanoma Res. pmid:14512786
Taba Y et al. 15-deoxy-delta 12,14-prostaglandin J2 and laminar fluid shear stress stabilize c-IAP1 in vascular endothelial cells. 2003 Am. J. Physiol. Heart Circ. Physiol. pmid:12623786
Fukuchi K et al. Apoptosis in human oral squamous cell carcinomas is induced by 15-deoxy-delta 12,14-prostaglandin J2 but not by troglitazone. 2003 J. Dent. Res. pmid:14514760
Józkowicz A et al. Prostaglandin-J(2) upregulates expression of matrix metalloproteinase-1 independently of activation of peroxisome proliferator-activated receptor-gamma. 2003 Acta Biochim. Pol. pmid:14515149
Imaizumi T et al. 15-Deoxy-delta 12,14-prostaglandin J2 inhibits the expression of granulocyte-macrophage colony-stimulating factor in endothelial cells stimulated with lipopolysaccharide. 2003 Prostaglandins Other Lipid Mediat. pmid:14518569
Lee CH and Edwards AM Differential expression of c-fos and c-myc protooncogenes by estrogens, xenobiotics and other growth-stimulatory agents in primary rat hepatocytes. 2003 Arch. Toxicol. pmid:12632255
Yoshimura R et al. The effect of peroxisome proliferator-activated receptor-gamma ligand on urological cancer cells. 2003 Int. J. Mol. Med. pmid:14612958
Okano H et al. The PPARgamma ligand, 15-Deoxy-Delta12,14-PGJ2, regulates apoptosis-related protein expression in cholangio cell carcinoma cells. 2003 Int. J. Mol. Med. pmid:14612959
Ajmone-Cat MA et al. Prolonged exposure of microglia to lipopolysaccharide modifies the intracellular signaling pathways and selectively promotes prostaglandin E2 synthesis. 2003 J. Neurochem. pmid:14622099
Shichijo M et al. Chemoattractant receptor-homologous molecule expressed on Th2 cells activation in vivo increases blood leukocyte counts and its blockade abrogates 13,14-dihydro-15-keto-prostaglandin D2-induced eosinophilia in rats. 2003 J. Pharmacol. Exp. Ther. pmid:12975488
Pierzchalska M et al. Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma. 2003 J. Allergy Clin. Immunol. pmid:12743569
Gao L et al. Formation of prostaglandins E2 and D2 via the isoprostane pathway: a mechanism for the generation of bioactive prostaglandins independent of cyclooxygenase. 2003 J. Biol. Chem. pmid:12746435
Kanbe E et al. DR1-like element in human topoisomerase IIalpha gene involved in enhancement of etoposide-induced apoptosis by PPARgamma ligand. 2003 Exp. Hematol. pmid:12691917
Jowsey IR et al. Expression of the murine glutathione S-transferase alpha3 (GSTA3) subunit is markedly induced during adipocyte differentiation: activation of the GSTA3 gene promoter by the pro-adipogenic eicosanoid 15-deoxy-Delta12,14-prostaglandin J2. 2003 Biochem. Biophys. Res. Commun. pmid:14652005
Zernecke A et al. Suppression of endothelial adhesion molecule up-regulation with cyclopentenone prostaglandins is dissociated from IkappaB-alpha kinase inhibition and cell death induction. 2003 FASEB J. pmid:12692090
Hammad H et al. Prostaglandin D2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor 1. 2003 J. Immunol. pmid:14530310
Garg TK and Chang JY Oxidative stress causes ERK phosphorylation and cell death in cultured retinal pigment epithelium: prevention of cell death by AG126 and 15-deoxy-delta 12, 14-PGJ2. 2003 BMC Ophthalmol pmid:12659653
Fukuda T [Trend in chemical mediator research in asthma and its application for asthma treatment]. 2003 Nihon Kokyuki Gakkai Zasshi pmid:14531291
Pérez-Sala D et al. Molecular basis for the direct inhibition of AP-1 DNA binding by 15-deoxy-Delta 12,14-prostaglandin J2. 2003 J. Biol. Chem. pmid:14532268
Chung YW et al. [Effects of peroxisome proliferator-activated receptor-gamma agonist on Fas-mediated apoptosis in HT-29 cells]. 2003 Korean J Gastroenterol pmid:14532729
Komar CM and Curry TE Inverse relationship between the expression of messenger ribonucleic acid for peroxisome proliferator-activated receptor gamma and P450 side chain cleavage in the rat ovary. 2003 Biol. Reprod. pmid:12700202
Worley JR et al. Metalloproteinase expression in PMA-stimulated THP-1 cells. Effects of peroxisome proliferator-activated receptor-gamma (PPAR gamma) agonists and 9-cis-retinoic acid. 2003 J. Biol. Chem. pmid:14534304
Bochenek G et al. A controlled study of 9alpha,11beta-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge. 2003 J. Allergy Clin. Immunol. pmid:12704352
Bernardo A et al. 15-deoxy-delta12,14-prostaglandin J2 regulates the functional state and the survival of microglial cells through multiple molecular mechanisms. 2003 J. Neurochem. pmid:14535956
Castaño E and Gil J 15-deoxy-delta12,14 prostaglandin J2 synergizes with phorbol ester to induce proliferation in Swiss 3T3 cells independently of peroxisome proliferator-activated receptor gamma and PGD2 receptors. 2003 J. Cell. Physiol. pmid:12704651
Ianaro A et al. 2-Cyclopenten-1-one and prostaglandin J2 reduce restenosis after balloon angioplasty in rats: role of NF-kappaB. 2003 FEBS Lett. pmid:14550540
Ando M et al. Retrovirally introduced prostaglandin D2 synthase suppresses lung injury induced by bleomycin. 2003 Am. J. Respir. Cell Mol. Biol. pmid:12707014
Imaizumi T et al. Effect of 15-deoxy-delta12,14-prostaglandin J2 on IL-1beta-induced expression of epithelial neutrophil-activating protein-78 in human endothelial cells. 2003 Prostaglandins Leukot. Essent. Fatty Acids pmid:14580366
Cippitelli M et al. The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms. 2003 J. Immunol. pmid:12707336
Heinemann A et al. Delta 12-prostaglandin J2, a plasma metabolite of prostaglandin D2, causes eosinophil mobilization from the bone marrow and primes eosinophils for chemotaxis. 2003 J. Immunol. pmid:12707356
Ye P et al. Activation of peroxisome proliferator-activated receptor alpha in human endothelial cells increases plasminogen activator inhibitor type-1 expression. 2003 Chin. Med. J. pmid:12667383
Kämpfer H et al. Cyclooxygenase-1-coupled prostaglandin biosynthesis constitutes an essential prerequisite for skin repair. 2003 J. Invest. Dermatol. pmid:12713596
Brown JR et al. Diminished production of anti-inflammatory mediators during neutrophil apoptosis and macrophage phagocytosis in chronic granulomatous disease (CGD). 2003 J. Leukoc. Biol. pmid:12714573
Tautenhahn A et al. Activation-induced PPARgamma expression sensitizes primary human T cells toward apoptosis. 2003 J. Leukoc. Biol. pmid:12714582
Desmond JC et al. The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs. 2003 Cancer Res. pmid:12543809
Tanaka H et al. Possible involvement of prostaglandins F(2alpha) and D(2) in acetylcholine-induced positive inotropy in isolated mouse left atria. 2003 Pharmacology pmid:12571412
Söderström M et al. Novel prostaglandin D(2)-derived activators of peroxisome proliferator-activated receptor-gamma are formed in macrophage cell cultures. 2003 Biochim. Biophys. Acta pmid:12573447
Gibbons H et al. Hypothermia suppresses inducible nitric oxide synthase and stimulates cyclooxygenase-2 in lipopolysaccharide stimulated BV-2 cells. 2003 Brain Res. Mol. Brain Res. pmid:12573534
Patel HJ et al. Activation of peroxisome proliferator-activated receptors in human airway smooth muscle cells has a superior anti-inflammatory profile to corticosteroids: relevance for chronic obstructive pulmonary disease therapy. 2003 J. Immunol. pmid:12594295
Ruan XZ et al. PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway. 2003 J. Am. Soc. Nephrol. pmid:12595494
Cuzzocrea S et al. The cyclopentenone prostaglandin 15-deoxy-delta(12,14)- PGJ2 attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the rat. 2003 Br. J. Pharmacol. pmid:12598422
Castrillo A et al. Potentiation of protein kinase C zeta activity by 15-deoxy-delta(12,14)-prostaglandin J(2) induces an imbalance between mitogen-activated protein kinases and NF-kappa B that promotes apoptosis in macrophages. 2003 Mol. Cell. Biol. pmid:12556480
Farrow B and Evers BM Activation of PPARgamma increases PTEN expression in pancreatic cancer cells. 2003 Biochem. Biophys. Res. Commun. pmid:12535639
Park EJ et al. 15d-PGJ2 and rosiglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS1) and SOCS3 in glia. 2003 J. Biol. Chem. pmid:12584205
Arici M et al. Stimulation of proximal tubular cell apoptosis by albumin-bound fatty acids mediated by peroxisome proliferator activated receptor-gamma. 2003 J. Am. Soc. Nephrol. pmid:12506134
Badawi AF and Badr MZ Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma and levels of prostaglandin E2 and 15-deoxy-delta12,14-prostaglandin J2 in human breast cancer and metastasis. 2003 Int. J. Cancer pmid:12455057
Weber SM et al. Inhibition of IFN-gamma -induced STAT1 activation by 15- deoxy-Delta 12,14-prostaglandin J2. 2003 Am. J. Physiol. Endocrinol. Metab. pmid:12517740
Pang L et al. Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors. 2003 J. Immunol. pmid:12517972
Neuschäfer-Rube F et al. Identification by site-directed mutagenesis of amino acids contributing to ligand-binding specificity or signal transduction properties of the human FP prostanoid receptor. 2003 Biochem. J. pmid:12519077
Calnek DS et al. Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells. 2003 Arterioscler. Thromb. Vasc. Biol. pmid:12524224
Hashimoto T et al. Effects of nonsteroidal anti-inflammatory drugs on experimental allergic conjunctivitis in Guinea pigs. 2003 J Ocul Pharmacol Ther pmid:14733714
Hirai H et al. Gene structure and functional properties of mouse CRTH2, a prostaglandin D2 receptor. 2003 Biochem. Biophys. Res. Commun. pmid:12878180
Zhang X et al. Unexpected sensitivity of synthetic Renilla luciferase control vectors to treatment with a cyclopentenone prostaglandin. 2003 BioTechniques pmid:14682047
Kanaoka Y and Urade Y Hematopoietic prostaglandin D synthase. 2003 Aug-Sep Prostaglandins Leukot. Essent. Fatty Acids pmid:12895599
Nagata K and Hirai H The second PGD(2) receptor CRTH2: structure, properties, and functions in leukocytes. 2003 Aug-Sep Prostaglandins Leukot. Essent. Fatty Acids pmid:12895600
Powell WS A novel PGD(2) receptor expressed in eosinophils. 2003 Aug-Sep Prostaglandins Leukot. Essent. Fatty Acids pmid:12895601
Kabashima K and Narumiya S The DP receptor, allergic inflammation and asthma. 2003 Aug-Sep Prostaglandins Leukot. Essent. Fatty Acids pmid:12895602
Moore RM et al. Physiological apoptotic agents have different effects upon human amnion epithelial and mesenchymal cells. 2003 Feb-Mar Placenta pmid:12566244
Kasim-Karakas SE et al. Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome. 2004 J. Clin. Endocrinol. Metab. pmid:14764771
Hirai H [Prostaglandin D2 in allergy: PGD2 has dual receptor systems]. 2004 Nippon Yakurigaku Zasshi pmid:14695454
Uehara Y [PGD(2)/L-PGDS system in hypertension and renal injury]. 2004 Nippon Yakurigaku Zasshi pmid:14695455
Miwa Y et al. Physiology and pharmacology of the prostaglandin J2 family. 2004 Nippon Yakurigaku Zasshi pmid:14695456
Abraha D et al. (S,S)-formoterol increases the production of IL-4 in mast cells and the airways of a murine asthma model. 2004 Int. Arch. Allergy Immunol. pmid:15031612
Rodway HA et al. Lysophosphatidic acid attenuates the cytotoxic effects and degree of peroxisome proliferator-activated receptor gamma activation induced by 15-deoxyDelta12,14-prostaglandin J2 in neuroblastoma cells. 2004 Biochem. J. pmid:15171682
Morii E and Oboki K MITF is necessary for generation of prostaglandin D2 in mouse mast cells. 2004 J. Biol. Chem. pmid:15375155
Subbarayan V et al. Differential peroxisome proliferator-activated receptor-gamma isoform expression and agonist effects in normal and malignant prostate cells. 2004 Cancer Epidemiol. Biomarkers Prev. pmid:15533897
Eucker J et al. Ligands of peroxisome proliferator-activated receptor gamma induce apoptosis in multiple myeloma. 2004 Anticancer Drugs pmid:15514564
Yoshida M et al. Methotrexate enhances prostaglandin D2-stimulated heat shock protein 27 induction in osteoblasts. 2004 Prostaglandins Leukot. Essent. Fatty Acids pmid:15519494
Giri S et al. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma. 2004 J. Immunol. pmid:15470065
Higashihara H et al. Hypoxia-reoxygenation enhances interleukin-8 production from U937 human monocytic cells. 2004 Redox Rep. pmid:15720834
Yoshimura-Uchiyama C et al. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2. 2004 Clin. Exp. Allergy pmid:15298571
Kielian T et al. S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta12,14- prostaglandin J2 (15d-PGJ2). 2004 J. Neurochem. pmid:15312171
Weber SM et al. PPARgamma ligands induce ER stress in pancreatic beta-cells: ER stress activation results in attenuation of cytokine signaling. 2004 Am. J. Physiol. Endocrinol. Metab. pmid:15315910
Szczeklik W et al. Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. 2004 J. Allergy Clin. Immunol. pmid:15316498
Ruiz PA et al. 15-deoxy-delta12,14-prostaglandin J2-mediated ERK signaling inhibits gram-negative bacteria-induced RelA phosphorylation and interleukin-6 gene expression in intestinal epithelial cells through modulation of protein phosphatase 2A activity. 2004 J. Biol. Chem. pmid:15199053
Shimomura K et al. Fenofibrate, troglitazone, and 15-deoxy-Delta12,14-prostaglandin J2 close KATP channels and induce insulin secretion. 2004 J. Pharmacol. Exp. Ther. pmid:15201343
Hawcroft G et al. Expression of prostaglandin D2 receptors DP1 and DP2 by human colorectal cancer cells. 2004 Cancer Lett. pmid:15172124
Son DJ et al. Antiplatelet effect of green tea catechins: a possible mechanism through arachidonic acid pathway. 2004 Prostaglandins Leukot. Essent. Fatty Acids pmid:15172681
Takeshita K et al. CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation. 2004 Int. Immunol. pmid:15173122